CD36 and HIV infectious disease: Although the mechanisms regulating CD36 expression during HIV infection and HAART remains to be elucidated, it is imperative to carefully evaluate the role of CD36 expression especially during HAART as this treatment is known to be associated with increased cardiovascular risk, hyeprlipidemia and lipodystrophy in HIV patients.